image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Medisys - Chief executive buys 2m shares

February 2003

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Medisys, which makes diabetes monitoring tests and safety syringes, has sorely tested the patience of investors with a string of delays to the launch of its key 3ml Futura, a retractable safety syringe.  But that hasn't dented the confidence of chief executive, David Wong, who purchased 2m shares  at 7.5p (worth £150,000),  on 11 December, taking his holding to 5.7%.   Soon after,  on 7 January, co-director, David Robbins bought 1m at 7.6p (worth £76,000).  Atfirst glance, there's little to get excited about in the short–term,with the launch of  Futura, which would take Medisys into the bigleague,  put back to the middle of this year.  But, Futura is a low cost automat ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMTED TIME OFFER

SUBSCRIBE TODAY AND SAVE £30 USING OFFER CODE 30OFFTMI

To access our archive of articles and receive current issues you need to subscribe